Biotech News
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors
ir.catalystbiosciences.com2026-05-06 15:21 EST
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, M.D., to